NP | Jotup

Eddy Smart Home Solutions Ltd. Provides Bi-Weekly Status Report on Management Cease Trade Order

Retrieved on:

Tuesday, May 16, 2023

Ontario Securities Commission, Bank statement, Annual, Financial statement, Person, KPMG LLP, EDY, NP, National Policy, KPMG, News, OSC, Cryptocurrency, Audit

TORONTO, May 16, 2023 (GLOBE NEWSWIRE) -- Eddy Smart Home Solutions Ltd. ("Eddy" or the "Company") (TSXV: EDY), is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”).

Key Points:

TORONTO, May 16, 2023 (GLOBE NEWSWIRE) -- Eddy Smart Home Solutions Ltd. ("Eddy" or the "Company") (TSXV: EDY), is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”).
The Company believes it will be able to file the Q1 2023 Filings by July 15, 2023.
The MCTO does not affect the ability of any other securityholders of the Company to trade securities of the Company.
The Company is working to complete the Annual Filing Documents and will continue to issue bi-weekly default status reports as required.

SpotLite360 Provides Bi-Weekly Status Report

Retrieved on:

Tuesday, May 16, 2023

CSE, Bank statement, British Columbia Securities Commission, Managed file transfer, NP, OTC, Annual Filing Season Program, National Policy, News

The Company reports that the audit is progressing and will provide a further update on the timing of its Annual Filings on or about May 30, 2023.

Key Points:

The Company reports that the audit is progressing and will provide a further update on the timing of its Annual Filings on or about May 30, 2023.
During the MCTO, the general investing public will continue to be able to trade in the Company's listed common shares.
However, the Company's Chief Executive Office and Chief Financial Officer will not be able to trade in the Company's common shares.
Other than as disclosed in this news release, there are no material changes to the information contained in the Default Announcement.

XTM Provides Update on Status of Financial Statements

Retrieved on:

Tuesday, May 16, 2023

Professional Services, Payments, Technology, Finance, Fintech, Banking, Ontario Securities Commission, PAID, Corporation, Product requirements document, XTM, OSC, Bank statement, NP, Audit

XTM Inc. ("XTM" or the "Corporation") (QB: XTMIF / CSE: PAID / FSE: 7XT) is providing an update to its previously announced management cease trade order (the "MCTO") granted by the Ontario Securities Commission (the “OSC”) under National Policy 12-203 - Management Cease Trade Orders ("NP 12-203").

Key Points:

XTM Inc. ("XTM" or the "Corporation") (QB: XTMIF / CSE: PAID / FSE: 7XT) is providing an update to its previously announced management cease trade order (the "MCTO") granted by the Ontario Securities Commission (the “OSC”) under National Policy 12-203 - Management Cease Trade Orders ("NP 12-203").
The MCTO does not affect the ability of other shareholders to trade their securities.
The Corporation has not yet filed the Required Documents, however XTM is working diligently with its auditors and expects that the Required Documents will be filed as soon as possible.
The delay in filing the required documents is in connection with to a recent change of auditor for the Corporation and audit requirements resulting from increased transaction volume experienced by the Corporation.

Emergia Inc. Provides Bi-Weekly Default Status Report

Retrieved on:

Tuesday, May 16, 2023

Executive, CSE, BCSC, Canadian Securities Exchange, Bank statement, Default, Annual, British Columbia Securities Commission, Part, Corporation, Financial statement, National instrument, NP, National Policy, Financial adviser, Security (finance)

MONTREAL, May 16, 2023 (GLOBE NEWSWIRE) -- (CSE: EMER) Emergia Inc. (the “Corporation or “Emergia”) is providing this default status report in accordance with National Policy 12-2023 Management Cease Trade Order (“NP 12-2023”) and the terms of a Management Cease Trade Order (“MCTO”) issued by the British Columbia Securities Commission (the “BCSC”) on May 2, 2023.

Key Points:

MONTREAL, May 16, 2023 (GLOBE NEWSWIRE) -- (CSE: EMER) Emergia Inc. (the “Corporation or “Emergia”) is providing this default status report in accordance with National Policy 12-2023 Management Cease Trade Order (“NP 12-2023”) and the terms of a Management Cease Trade Order (“MCTO”) issued by the British Columbia Securities Commission (the “BCSC”) on May 2, 2023.
Pursuant to NP 12-203, the Corporation must file bi-weekly default status reports in the form of new releases until the MCTO is revoked.
Accordingly, the Corporation confirms that since the Default Announcement:
There have been no changes to the information contained in the Company’s May 2.
The Corporation expects to file the Annual Financial Filings on or before June 30, 2023.

Voxtur Provides Bi-Weekly Status Report of Management Cease Trade Order

Retrieved on:

Monday, May 15, 2023

Chief, Ontario Securities Commission, Bank statement, SEC filing, NP, Section 21 notice, News, Audit, Notice

TORONTO and TAMPA, Fla., May 15, 2023 (GLOBE NEWSWIRE) -- Voxtur Analytics Corp. (TSXV: VXTR; OTCQB: VXTRF) ("Voxtur" or the "Company"), is providing this bi-weekly status report in accordance with National Policy 12-203 - Management Cease Trade Orders ("NP 12-203").

Key Points:

TORONTO and TAMPA, Fla., May 15, 2023 (GLOBE NEWSWIRE) -- Voxtur Analytics Corp. (TSXV: VXTR; OTCQB: VXTRF) ("Voxtur" or the "Company"), is providing this bi-weekly status report in accordance with National Policy 12-203 - Management Cease Trade Orders ("NP 12-203").
The Ontario Securities Commission, as the Company's principal regulator in Canada, granted a temporary management cease trade order ("MCTO") on May 5, 2023.
The Company is working closely with its auditors to complete the Required Filings by June 30, 2023.
The Company believes it will be able to file the Q1 2023 Filings by July 7, 2023.

Titan Medical Provides Bi-Weekly MCTO Status Update

Retrieved on:

Monday, May 15, 2023

Titan, TMD, Ontario Securities Commission, Bank statement, Annual, Suspension, Exchange, NP, Certification, TSX, Form 6-K, National Policy, OSC

TORONTO, Ontario, May 15, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF) is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”).

Key Points:

TORONTO, Ontario, May 15, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF) is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”).
The MCTO was granted by the OSC on April 3, 2023.
The MCTO does not affect the ability of shareholders who are not named in the MCTO to trade their securities.
The Company has previously disclosed that it intends to file the Annual Filing Documents by May 19, 2023.

Cleantech Power Corp. Provides Update on Status of MCTO and Correction on Warrant Amendments

Retrieved on:

Monday, May 15, 2023

WKN, Bank statement, NEO Exchange, Exchange, British Columbia Securities Commission, SEC filing, E43, NP, Warrant, Annual Filing Season Program, National Policy, News, NEO, Security (finance)

The Company reports that the audit is progressing and will provide a further update on the timing of its Annual Filings on or about May 29, 2023.

Key Points:

The Company reports that the audit is progressing and will provide a further update on the timing of its Annual Filings on or about May 29, 2023.
During the MCTO, the general investing public will continue to be able to trade in the Company's listed common shares.
However, the Company's Chief Executive Officer and Chief Financial Officer will not be able to trade in the Company's common shares.
The Warrant Amendments were passed unanimously by the board of directors of the Company.

Cara Therapeutics Reports First Quarter 2023 Financial Results

Retrieved on:

Monday, May 15, 2023

STAMFORD, Conn., May 15, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced financial results and operational highlights for the first quarter ended March 31, 2023.

Key Points:

– Conference call today at 4:30 p.m. EDT –
STAMFORD, Conn., May 15, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced financial results and operational highlights for the first quarter ended March 31, 2023.
“The U.S. and global launches of KORSUVA® (difelikefalin) injection / Kapruvia® gained momentum in the first quarter of 2023.
Wholesalers shipped 45,720 vials to dialysis centers, the majority of which were Fresenius clinics, during the first quarter of 2023.
Vial orders more than doubled quarter to quarter, signifying an acceleration in patient demand.

Gatos Silver Provides Bi-Weekly Status Report

Retrieved on:

Friday, May 12, 2023

VANCOUVER, British Columbia, May 12, 2023 (GLOBE NEWSWIRE) -- Gatos Silver, Inc. (NYSE/TSX: GATO) (“Gatos Silver” or the “Company”) is providing this bi-weekly default status report in accordance with National Policy 12-203 - Management Cease Trade Orders (“NP 12-203”).

Key Points:

VANCOUVER, British Columbia, May 12, 2023 (GLOBE NEWSWIRE) -- Gatos Silver, Inc. (NYSE/TSX: GATO) (“Gatos Silver” or the “Company”) is providing this bi-weekly default status report in accordance with National Policy 12-203 - Management Cease Trade Orders (“NP 12-203”).
On March 31, 2023, the Company announced the reason for the delay and that it will need to restate its 2021 Annual Filings and 2022 Quarterly Filings.
The Company is continuing to assess the impact of these material weaknesses and whether any other material weaknesses exist.
Pursuant to NP 12-203, the Company must file bi-weekly status reports in the form of further news releases during the period from the Notice until the MCTO is revoked.

NP Digital Honored as Best Workplace 2023 by Inc. Magazine

Retrieved on:

Wednesday, May 10, 2023

Workplace, Heart, DEI, Growth, Digital, Infertility, 100 Best Workplaces in Europe, SAN, Culture, NP, Management, Nursing

SAN DIEGO, May 10, 2023 (GLOBE NEWSWIRE) -- NP Digital , a leader in end-to-end performance marketing, has been named to Inc. Magazine’s annual Best Workplaces list for the second year in a row.

Key Points:

SAN DIEGO, May 10, 2023 (GLOBE NEWSWIRE) -- NP Digital , a leader in end-to-end performance marketing, has been named to Inc. Magazine’s annual Best Workplaces list for the second year in a row.
The recognition results from a comprehensive measurement of direct employee feedback on the company’s culture, benefits, career opportunities, and leadership.
NP Digital is acknowledged for its culture of compassionate management, transparent leadership, talented colleagues, fun and fulfilling work, and commitment to providing exceptional benefits that surpass other agencies.
A 97% engagement rate among employees places NP Digital among the top-scoring best places to work, according to Inc.
“We are committed to creating an inclusive culture and providing benefits that enhance our employees' lives and well-being and allow them to thrive both in and outside of the workplace,” said Mike Gullaksen, CEO of NP Digital.